🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study benefits the community by highlighting the potential of a gluten...
Status
Completed
Location
Sana Noreen
Start Date
2025-01-10
Trial ID
NCT07127055
Treatments Being Tested
Celiac disease (CD) is an immunological disorder that mainly affects the sm...
Status
Completed
Location
University of Alicante
Start Date
2018-09-01
Trial ID
NCT05052164
This is a prospective, observational, online study of people diagnosed with...
Status
Recruiting
Location
Virtual
Start Date
2026-01-26
Trial ID
NCT07233148
Treatments Being Tested
This is a prospective, randomized, double-blind, placebo-controlled explora...
Status
Recruiting
Location
McMaster University
Start Date
2022-12-01
Trial ID
NCT05576038
Treatments Being Tested
Celiac is a chronic autoimmune disease that is treated with a gluten-free d...
Status
Completed
Location
Bursa Uludağ University
Start Date
2022-01-01
Trial ID
NCT05474976
The goal is to evaluate gastrointestinal symptoms and fatigue levels during...
Status
Completed
Location
Hospital of Southern Jutland
Start Date
2024-03-11
Trial ID
NCT06249763
Treatments Being Tested
This investigation examines the most important cardiovascular risk factors ...
Status
Recruiting
Location
First Department of Medicine, Medical School, University of Pécs
Start Date
2022-09-01
Trial ID
NCT05530070
Treatments Being Tested
This study aims to evaluate the effects of different dietary interventions,...
Status
Recruiting
Location
NCR International Hospital
Start Date
2025-10-29
Trial ID
NCT07646262
Treatments Being Tested
The rationale for this study is to observe the effect of two different dose...
Status
Active Not Recruiting
Location
People Science, Inc.
Start Date
2024-07-24
Trial ID
NCT06782945
Treatments Being Tested
A PROSPECTIVE, double blind, placebo-controlled trial...
Status
Completed
Location
Angelo Andriulli
Start Date
2017-03-20
Trial ID
NCT03137862
Treatments Being Tested